JH

James Hardiman

Investor at NOETIK

San Francisco, California

Overview 

James Hardiman is a General Partner at DCVC, specializing in early-stage investments in applied AI and deep tech. With a background in finance and strategy, he has successfully invested in companies like Valar Labs and Gradle Inc., demonstrating a strong track record in venture capital. Hardiman's role at DCVC involves leading investments in Series A, Series B, and seed-stage companies across sectors like DeepTech, AI, and IoT, showcasing his expertise in identifying and supporting innovative startups in the San Francisco Bay Area.

Work Experience 

  • Investor and Board Observer

    2023 - Current

    Clean Ammonia on Demand

  • General Partner

    2013

    With more than $4B AUM, DCVC backs entrepreneurs solving trillion-dollar problems to multiply the benefits of capitalism for everyone while reducing its costs.

DCVC backs entrepreneurs using deep tech to solve problems and multiply the benefits of capitalism for everyone while reducing its cost.

  • Investor and Board Observer

    2017

    Decoding biology to radically improve lives Board Observer 2017 to 2020

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Raised $865,376,000.00 from NVIDIA, Laurion Capital Management, Invus, Baillie Gifford, Kinnevik, Mubadala Capital Ventures and Platinum Asset Management.

  • Investor and Board Director

    2023

    AI diagnostics to interpret solid tumors, so physicians and patients can make evidence-based decisions about cancer treatments

  • Investor and Board Director

    2022

    An AI-native biotechnology company harnessing self-supervised learning and human multimodal data for better precision immunotherapies.

  • Investor and Board Director

    2021

    Developing single cell platforms to unlock a key bottleneck in immunotherapy, enabling curative treatments.

ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.

Raised $13,000,000.00 from Foundation Capital, DCVC, Jasper Lau, AV8 Ventures and Mei Z..

  • Investor and Board Director

    2020

    The world's first accessible X-Ray CT scanner for engineers

Lumafield is an accessible X-ray CT platform that gives engineers better insights into product development and manufacturing.

Raised $67,500,000.00 from Shane Neman, Spark Capital, Lux Capital, Kleiner Perkins, Future Shape and DataCollective.

  • Investor and Board Director

    2020

    Transforming how software is built and shipped.

  • Investor and Board Director

    2020

  • Investor and Board Director

    2017

    Engineering software for advanced manufacturing

nTopology is a company that develops software used in the design and manufacturing of 3D-printed parts and products.

Raised $135,200,000.00 from Insight Partners, Root Ventures, Haystack, DCVC, Oldslip, Tiger Global Management and Canaan Partners.

Articles About James

Relevant Websites